ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 168 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,750 | +114.4% | 183 | +108.0% | 0.00% | – |
| Q2 2023 | $1,749 | +16.1% | 88 | 0.0% | 0.00% | – |
| Q1 2023 | $1,507 | -12.5% | 88 | 0.0% | 0.00% | – |
| Q4 2022 | $1,722 | +72.2% | 88 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 88 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -90.0% | 88 | -62.7% | 0.00% | -100.0% |
| Q1 2021 | $10,000 | -88.6% | 236 | -85.2% | 0.00% | -90.9% |
| Q4 2020 | $88,000 | +125.6% | 1,600 | -5.9% | 0.02% | +100.0% |
| Q3 2020 | $39,000 | +85.7% | 1,700 | +13.3% | 0.01% | +37.5% |
| Q1 2020 | $21,000 | -38.2% | 1,500 | 0.0% | 0.01% | -33.3% |
| Q4 2019 | $34,000 | -2.9% | 1,500 | -50.0% | 0.01% | -7.7% |
| Q3 2019 | $35,000 | +133.3% | 3,000 | +200.0% | 0.01% | +116.7% |
| Q2 2019 | $15,000 | +114.3% | 1,000 | +100.0% | 0.01% | +100.0% |
| Q4 2018 | $7,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 665,880 | $10,627,000 | 11.09% |
| RTW INVESTMENTS, LP | 15,802,802 | $252,213,000 | 5.82% |
| Ally Bridge Group (NY) LLC | 479,506 | $7,653,000 | 5.05% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,204,000 | 2.48% |
| TIGER MANAGEMENT L.L.C. | 279,700 | $4,464,000 | 1.95% |
| Prosight Management, LP | 200,000 | $3,192,000 | 1.71% |
| COWEN AND COMPANY, LLC | 999,588 | $15,953,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,398,000 | 1.32% |
| Affinity Asset Advisors, LLC | 267,794 | $4,274,000 | 1.19% |
| HARBOR CAPITAL ADVISORS, INC. | 66,410 | $1,060,000 | 0.97% |